Chas McKhann - 18 Aug 2021 Form 4/A - Amendment Insider Report for Apollo Endosurgery, Inc.

Signature
/s/ Brian Szymczak - Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
18 Aug 2021
Net transactions value
-$504,234
Form type
4/A - Amendment
Filing time
20 Aug 2021, 20:55:06 UTC
Date Of Original Report
20 Aug 2021
Next filing
09 May 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APEN Common Stock Sale $173,691 -21,156 -3% $8.21 686,122 18 Aug 2021 Direct F1, F2
transaction APEN Common Stock Sale $166,858 -21,148 -3.1% $7.89 664,974 19 Aug 2021 Direct F1, F3
transaction APEN Common Stock Sale $163,686 -21,148 -3.2% $7.74 643,826 20 Aug 2021 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 10, 2021, the holder was granted 707,278 performance-based restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 12, 2021. One-quarter (25%) of these RSUs vested upon the Company's achievement of at least $50 million of revenue for the trailing four quarters ended June 30, 2021. Amounts reported represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs.
F2 Represents weighted average price of shares sold. Prices ranged between $8.02 - $8.55, inclusive. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Represents weighted average price of shares sold. Prices ranged between $7.68 - $8.15, inclusive. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 Represents weighted average price of shares sold. Prices ranged between $7.59 - $8.09, inclusive. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

Added new footnote 1 above to clarify the nature of the sales of shares of common stock.